TriTAC® Technology
Watch our TriTAC technology unleash the target cell-killing properties of a patient’s own immune system.
Science
Harpoon has created a novel antibody-based drug discovery platform called TriTAC®, which offers a new way to unleash the target cell-killing properties of a patient’s own immune system.
Careers
Harpoon is seeking energetic, passionate scientists and innovators to join our effort.
Recent News
October 4,
2022
Harpoon Therapeutics Appoints Luke Walker, M.D., as Chief Medical Officer
September 19,
2022
Harpoon Therapeutics Appoints Lauren Silvernail to Board of Directors